BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 57,451 Value ($000) $436 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 21,896 Value ($000) $196 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 69,860 Value ($000) $524 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 54,446 Value ($000) $409 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 39,520 Value ($000) $300 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 142,359 Value ($000) $880 Avg Close $5.52 Range $4.03 - $6.99
Q4 2023
Shares 31,510 Value ($000) $189 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 48,980 Value ($000) $347 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 30,680 Value ($000) $216 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 22,280 Value ($000) $186 Avg Close $9.63 Range $7.82 - $12.08
Q1 2022
Shares 15,513 Value ($000) $252 Avg Close $16.04 Range $11.56 - $19.99
Q2 2021
Shares 14,634 Value ($000) $231 Avg Close $13.59 Range $9.23 - $17.74
Q3 2020
Shares 541,839 Value ($000) $1,861 Avg Close $4.29 Range $3.30 - $6.03